Glucose control in the critically ill.
Schetz
M
M
Department of Intensive Care Medicine, University Hospital Gasthuisberg, Leuven, Belgium. marie.schetz@uz.kuleuven.ac.be
Van den Berghe
G
G
D001778:Blood Coagulation Disorders / Q000517:prevention & control; D001786:Blood Glucose / Q000378:metabolism*; D016638:Critical Illness / Q000628:therapy*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007154:Immune System Diseases / Q000209:etiology; D007239:Infections / Q000209:etiology; D007249:Inflammation / Q000517:prevention & control; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D007362:Intensive Care Units; D009422:Nervous System Diseases / Q000209:etiology; D051437:Renal Insufficiency / Q000209:etiology; D012307:Risk Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin